44 results on '"Matsuo, K"'
Search Results
2. Utilization of hysteroscopic endometrial sampling for patients with endometrial hyperplasia
- Author
-
Ciesielski, K., primary, Mann, P., additional, Mandelbaum, R., additional, Roman, L., additional, Wright, J., additional, and Matsuo, K., additional
- Published
- 2023
- Full Text
- View/download PDF
3. Temporal trends of hysterectomy modality for uterine prolapse in the united states, 2016-2019
- Author
-
Deshpande, R., primary, Foy, O., additional, Mandelbaum, R., additional, Dancz, C., additional, and Matsuo, K., additional
- Published
- 2023
- Full Text
- View/download PDF
4. Reconstructive surgery at hysterectomy for patients with uterine prolapse and gynecologic malignancy
- Author
-
Foy, O., primary, Deshpande, R., additional, Mandelbaum, R., additional, Roman, L., additional, Wright, J., additional, Dancz, C., additional, and Matsuo, K., additional
- Published
- 2023
- Full Text
- View/download PDF
5. Concurrent gynecologic surgery at laparoscopic cholecystectomy: assessment of real-world practice
- Author
-
Rau, A.R., primary, Ciesielski, K., additional, Mandelbaum, R., additional, Roman, L., additional, Matsushima, K., additional, Wright, J., additional, and Matsuo, K., additional
- Published
- 2023
- Full Text
- View/download PDF
6. Temporal trends of opportunistic salpingectomy at time of hysterectomy for pre-invasive gynecologic malignancy
- Author
-
Ciesielski, K., primary, Mandelbaum, R., additional, McGough, A., additional, Roman, L., additional, and Matsuo, K., additional
- Published
- 2023
- Full Text
- View/download PDF
7. Temporal trends of hysterectomy modality for pre-malignant gynecologic pathology in the united states from 2016 to 2019
- Author
-
Mann, P., primary, Rau, A.R., additional, Mandelbaum, R., additional, Roman, L., additional, and Matsuo, K., additional
- Published
- 2023
- Full Text
- View/download PDF
8. Distinct obstetric characteristics and maternal mortality in patients with HELLP syndrome versus severe pre-eclampsia.
- Author
-
Kuhn JN, Mazza GR, Matsuzaki S, Pon FF, Yao JA, Yu E, Mandelbaum RS, Ouzounian JG, and Matsuo K
- Published
- 2024
- Full Text
- View/download PDF
9. Racial and ethnic differences in early death among gynecologic malignancy.
- Author
-
Lee MW, Vallejo A, Furey KB, Woll SM, Klar M, Roman LD, Wright JD, and Matsuo K
- Subjects
- Humans, Female, Middle Aged, United States epidemiology, Aged, Adult, Ethnicity statistics & numerical data, Uterine Cervical Neoplasms mortality, Uterine Cervical Neoplasms ethnology, Ovarian Neoplasms mortality, Ovarian Neoplasms ethnology, Asian statistics & numerical data, Uterine Neoplasms mortality, Uterine Neoplasms ethnology, Genital Neoplasms, Female mortality, Genital Neoplasms, Female ethnology, SEER Program, White People statistics & numerical data, Black or African American statistics & numerical data, Hispanic or Latino statistics & numerical data
- Abstract
Background: Racial and ethnic differences in early death after cancer diagnosis have not been well studied in gynecologic malignancy., Objective: This study aimed to assess population-level trends and characteristics of early death among patients with gynecologic malignancy based on race and ethnicity in the United States., Study Design: The National Cancer Institute's Surveillance, Epidemiology, and End Results Program was queried to examine 461,300 patients with gynecologic malignancies from 2000 to 2020, including uterine (n=242,709), tubo-ovarian (n=119,989), cervical (n=68,768), vulvar (n=22,991), and vaginal (n=6843) cancers. Early death, defined as a mortality event within 2 months of the index cancer diagnosis, was evaluated per race and ethnicity., Results: At the cohort level, early death occurred in 21,569 patients (4.7%), including 10.5%, 5.5%, 2.9%, 2.5%, and 2.4% for tubo-ovarian, vaginal, cervical, uterine, and vulvar cancers, respectively (P<.001). In a race- and ethnicity-specific analysis, non-Hispanic Black patients with tubo-ovarian cancer had the highest early death rate (14.5%). Early death racial and ethnic differences were the largest in tubo-ovarian cancer (6.4% for Asian vs 14.5% for non-Hispanic Black), followed by uterine (1.6% for Asian vs 4.9% for non-Hispanic Black) and cervical (1.8% for Hispanic vs 3.8% to non-Hispanic Black) cancers (all, P<.001). In tubo-ovarian cancer, the early death rate decreased over time by 33% in non-Hispanic Black patients from 17.4% to 11.8% (adjusted odds ratio, 0.67; 95% confidence interval, 0.53-0.85) and 23% in non-Hispanic White patients from 12.3% to 9.5% (adjusted odds ratio, 0.77; 95% confidence interval, 0.71-0.85), respectively. The early death between-group difference diminished only modestly (12.3% vs 17.4% for 2000-2002 [adjusted odds ratio for non-Hispanic White vs non-Hispanic Black, 0.54; 95% confidence interval, 0.45-0.65] and 9.5% vs 11.8% for 2018-2020 [adjusted odds ratio, 0.65; 95% confidence interval, 0.54-0.78])., Conclusion: Overall, approximately 5% of patients with gynecologic malignancy died within the first 2 months from cancer diagnosis, and the early death rate exceeded 10% in non-Hispanic Black individuals with tubo-ovarian cancer. Although improving early death rates is encouraging, the difference among racial and ethnic groups remains significant, calling for further evaluation., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
10. Fertility-preserving treatment for stage IA endometrial cancer: a systematic review and meta-analysis.
- Author
-
Suzuki Y, Ferris JS, Chen L, Dioun S, Usseglio J, Matsuo K, Xu X, Hershman DL, and Wright JD
- Abstract
Objective: The increasing use of fertility-preserving treatments in reproductive-aged patients with early-stage endometrial cancer necessitates robust evidence on the effectiveness of oral progestins and levonorgestrel-releasing intrauterine device. We conducted a systematic review and meta-analysis to examine the outcomes following these 2 primary progestin-based therapies in reproductive-aged patients with early-stage endometrial cancer., Data Sources: We conducted a systematic review of observational studies and randomized controlled trials following the Cochrane Handbook guidance. We conducted a literature search of 5 databases and 1 trial registry from inception of the study to April 16, 2024., Study Eligibility Criteria: Studies reporting complete response within 1 year in reproductive-aged patients with clinical stage IA endometrioid cancer undergoing progestin therapy treatment were included. We used data from both observational and randomized controlled studies., Study Appraisal and Synthesis Methods: The primary exposure assessed was the type of progestational treatment (oral progestins or LNG-IUD). The primary outcome was the pooled proportion of the best complete response (CR) within 1 year of primary progestational treatment. We performed a proportional meta-analysis to estimate the treatment response. Sensitivity analyses were performed by removing studies with extreme effect sizes or removing grade 2 tumors. The risk of bias was assessed in each study using the Joanna Briggs Institute critical appraisal checklist., Results: Our analysis involved 754 reproductive-aged patients diagnosed with endometrial cancer, with 490 receiving oral progestin and 264 receiving levonorgestrel-releasing intrauterine device as their primary progestational treatment. The pooled proportion of the best complete response within 12 months of oral progestin and levonorgestrel-releasing intrauterine device treatment were 66% (95% CI, 55-76) and 86% (95% CI, 69-95), respectively. After removing outlier studies, the pooled proportion was 66% (95% CI, 57-73) for the oral progestin group and 89% (95% CI, 75-96) for the levonorgestrel-releasing intrauterine device group, showing reduced heterogeneity. Specifically, among studies including grade 1 tumors, the pooled proportions were 66% (95% CI, 54-77) for the oral progestin group and 83% (95% CI, 50-96) for the levonorgestrel-releasing intrauterine device group. The pooled pregnancy rate was 58% (95% CI, 37-76) after oral progestin treatment and 44% (95% CI, 6-90) after levonorgestrel-releasing intrauterine device treatment., Conclusion: This meta-analysis provides valuable insights into the effectiveness of oral progestins and levonorgestrel-releasing intrauterine device treatment within a 12-month timeframe for patients with early-stage endometrial cancer who desire to preserve fertility. These findings have the potential to assist in personalized treatment decision-making for patients., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
11. Posterior reversible encephalopathy syndrome following eclampsia: assessment of clinical and pregnancy characteristics.
- Author
-
Yu E, Green JM, Aberle LS, Mandelbaum RS, Brueggmann D, Ouzounian JG, and Matsuo K
- Subjects
- Humans, Female, Pregnancy, Adult, Magnetic Resonance Imaging, Posterior Leukoencephalopathy Syndrome diagnostic imaging, Posterior Leukoencephalopathy Syndrome diagnosis, Posterior Leukoencephalopathy Syndrome etiology, Eclampsia diagnosis
- Published
- 2024
- Full Text
- View/download PDF
12. Temporal trends of obstetric hemorrhage and product-specific blood transfusion at time of delivery.
- Author
-
Sangara RN, Matsushima K, Matsuzaki S, Yao JA, Yu E, Mandelbaum RS, Grubbs BH, Incerpi MH, Ouzounian JG, and Matsuo K
- Published
- 2024
- Full Text
- View/download PDF
13. Research on intrauterine manipulators for endometrial cancer: attention to study-level characteristics.
- Author
-
Guo XM, Lim LM, Matsuzaki S, and Matsuo K
- Subjects
- Female, Humans, Hysterectomy, Levonorgestrel, Endometrial Neoplasms surgery, Intrauterine Devices, Medicated
- Published
- 2024
- Full Text
- View/download PDF
14. Assessment of uterine rupture in placenta accreta spectrum: pre-labor vs in-labor.
- Author
-
Komatsu EJ, Matsuzaki S, Mazza GR, Brueggmann D, Mandelbaum RS, Ouzounian JG, and Matsuo K
- Subjects
- Pregnancy, Female, Humans, Retrospective Studies, Placenta, Uterine Rupture etiology, Placenta Accreta diagnostic imaging, Labor, Obstetric, Placenta Diseases, Placenta Previa
- Published
- 2024
- Full Text
- View/download PDF
15. Trends in the use of indocyanine green for sentinel lymph node mapping in vulvar cancer.
- Author
-
Matsuo K, Chen L, Robison K, Klar M, Roman LD, and Wright JD
- Subjects
- Female, Humans, Indocyanine Green, Sentinel Lymph Node Biopsy, Lymph Nodes diagnostic imaging, Lymph Nodes pathology, Coloring Agents, Lymph Node Excision, Vulvar Neoplasms surgery, Vulvar Neoplasms pathology, Sentinel Lymph Node pathology
- Published
- 2023
- Full Text
- View/download PDF
16. Substantial variability in ovarian conservation at hysterectomy for endometrial hyperplasia.
- Author
-
Matsuo K, Violette CJ, Mandelbaum RS, Harris CA, Tavakoli A, Klar M, Shoupe D, and Roman LD
- Subjects
- Female, Humans, Hysterectomy, Ovariectomy, Ovary surgery, Retrospective Studies, Endometrial Hyperplasia pathology, Endometrial Hyperplasia surgery, Endometrial Neoplasms pathology, Precancerous Conditions surgery
- Abstract
Background: Although ovarian conservation at hysterectomy for benign gynecologic disease has demonstrated mortality benefit in young patients and this benefit may be sustained up to age 65 years, there is a scarcity of data regarding ovarian conservation in those with a diagnosis of endometrial hyperplasia, a premalignant uterine condition., Objective: This study aimed to examine patient, hospital, treatment, and histology characteristics related to ovarian conservation at the time of inpatient hysterectomy for endometrial hyperplasia., Study Design: The Healthcare Cost and Utilization Project's National Inpatient Sample was retrospectively queried to examine patients aged ≤65 years with endometrial hyperplasia who had inpatient hysterectomy from January 2016 to December 2019. The exclusion criteria included concurrent gynecologic malignancy, adnexal pathology, and lymphadenectomy. Cases were grouped by adnexal surgery status (ovarian conservation or oophorectomy). A multivariable binary logistic regression model was used to identify independent characteristics for ovarian conservation. A classification tree was constructed with recursive partitioning analysis to examine utilization patterns of ovarian conservation., Results: Overall, 3105 patients (31.1%) underwent ovarian conservation at hysterectomy among 9975 patients. The utilization of ovarian conservation decreased gradually until age 45 years and then markedly decreased by age 52 years (63.3%-15.3%; P<.001). In a multivariable analysis, younger age, non-White, urban nonteaching centers, and vaginal hysterectomy were associated with increased utilization of ovarian conservation, whereas endometrial hyperplasia with atypia, obesity, comorbidity, large bed capacity centers, and Midwest and South regions were associated with decreased utilization of ovarian conservation (all, P<.05). A classification tree identified 17 utilization patterns for ovarian conservation, ranging from 7.8% to 100.0% (absolute rate difference, 92.2%)., Conclusion: The utilization of ovarian conservation at the time of inpatient hysterectomy in patients undergoing surgical management for endometrial hyperplasia started decreasing in their mid-40s and seemed to occur earlier than in benign hysterectomy. There was substantial variability in ovarian conservation at the time of hysterectomy for endometrial hyperplasia based on patient, hospital, surgical, and histology factors, suggesting the possible benefit of clinical practice guidelines for ovarian conservation in this population., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
17. Conservative management of placenta percreta: is current evidence sufficient?
- Author
-
Matsuzaki S, Youssefzadeh AC, and Matsuo K
- Subjects
- Cesarean Section, Conservative Treatment, Female, Humans, Hysterectomy, Pregnancy, Placenta Accreta surgery
- Published
- 2022
- Full Text
- View/download PDF
18. Sentinel lymph node biopsy for vulvar melanoma: trends in tumor stage-specific utilization.
- Author
-
Bainvoll L, Brunette LL, Muderspach LI, Khetan VU, Roman LD, Klar M, and Matsuo K
- Subjects
- Female, Humans, Lymph Node Excision, Lymph Nodes pathology, Neoplasm Staging, Sentinel Lymph Node Biopsy, Melanoma pathology, Sentinel Lymph Node pathology, Skin Neoplasms pathology, Vulvar Neoplasms pathology
- Published
- 2022
- Full Text
- View/download PDF
19. In reply: Is twin gestation an independent risk factor for placenta accreta spectrum?
- Author
-
Matsuzaki S, Mandelbaum RS, and Matsuo K
- Subjects
- Female, Humans, Pregnancy, Risk Factors, United States, Placenta Accreta diagnostic imaging, Placenta Accreta epidemiology
- Published
- 2022
- Full Text
- View/download PDF
20. Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States.
- Author
-
Matsuzaki S, Mandelbaum RS, Sangara RN, McCarthy LE, Vestal NL, Klar M, Matsushima K, Amaya R, Ouzounian JG, and Matsuo K
- Subjects
- Adult, Age Factors, Aged, Blood Coagulation Disorders epidemiology, Breech Presentation, Cesarean Section statistics & numerical data, Comorbidity, Databases, Factual, Female, Hospital Bed Capacity, Hospital Mortality, Hospitals, Teaching, Hospitals, Urban, Humans, Hysterectomy statistics & numerical data, Length of Stay economics, Middle Aged, Multivariate Analysis, Parity, Placenta Accreta surgery, Postpartum Hemorrhage epidemiology, Pregnancy, Reproductive Techniques, Assisted, Retrospective Studies, Tobacco Use epidemiology, United States epidemiology, Urinary Tract injuries, Placenta Accreta epidemiology
- Abstract
Background: Although an infrequent occurrence, the placenta can adhere abnormally to the gravid uterus leading to significantly high maternal morbidity and mortality during cesarean delivery. Contemporary national statistics related to a morbidly adherent placenta, referred to as placenta accreta spectrum, are needed., Objective: This study aimed to examine national trends, characteristics, and perioperative outcomes of women who underwent cesarean delivery for placenta accreta spectrum in the United States., Study Design: This is a population-based retrospective, observational study querying the National Inpatient Sample. The study cohort included women who underwent cesarean delivery from October 2015 to December 2017 and had a diagnosis of placenta accreta spectrum. The main outcome measures were patient characteristics and surgical outcomes related to placenta accreta spectrum assessed by the generalized estimating equation on multivariable analysis. The temporal trend of placenta accreta spectrum was also assessed by linear segmented regression with log transformation., Results: Of 2,727,477 cases who underwent cesarean delivery during the study period, 8030 (0.29%) had the diagnosis of placenta accreta spectrum. Placenta accreta was the most common diagnosis (n=6205, 0.23%), followed by percreta (n=1060, 0.04%) and increta (n=765, 0.03%). The number of placenta accreta spectrum cases increased by 2.1% every quarter year from 0.27% to 0.32% (P=.004). On multivariable analysis, (1) patient demographics (older age, tobacco use, recent diagnosis, higher comorbidity, and use of assisted reproductive technology), (2) pregnancy characteristics (placenta previa, previous cesarean delivery, breech presentation, and grand multiparity), and (3) hospital factors (urban teaching center and large bed capacity hospital) represented the independent characteristics related to placenta accreta spectrum (all, P<.05). The median gestational age at cesarean delivery was 36 weeks for placenta accreta and 34 weeks for both placenta increta and percreta vs 39 weeks for non-placenta accreta spectrum cases (P<.001). On multivariable analysis, cesarean delivery complicated by placenta accreta spectrum was associated with increased risk of any surgical morbidities (78.3% vs 10.6%), Centers for Disease Control and Prevention-defined severe maternal morbidity (60.3% vs 3.1%), hemorrhage (54.1% vs 3.9%), coagulopathy (5.3% vs 0.3%), shock (5.0% vs 0.1%), urinary tract injury (8.3% vs 0.2%), and death (0.25% vs 0.01%) compared with cesarean delivery without placenta accreta spectrum. When further analyzed by subtype, cesarean delivery for placenta increta and percreta was associated with higher likelihood of hysterectomy (0.4% for non-placenta accreta spectrum, 45.8% for accreta, 82.4% for increta, 78.3% for percreta; P<.001) and urinary tract injury (0.2% for non-placenta accreta spectrum, 5.2% for accreta, 11.8% for increta, 24.5% for percreta; P<.001). Moreover, women in the placenta increta and percreta groups had markedly increased risks of surgical mortality compared with those without placenta accreta spectrum (increta, odds ratio, 19.9; and percreta, odds ratio, 32.1)., Conclusion: Patient characteristics and outcomes differ across the placenta accreta spectrum subtypes, and women with placenta increta and percreta have considerably high surgical morbidity and mortality risks. Notably, 1 in 313 women undergoing cesarean delivery had a diagnosis of placenta accreta spectrum by the end of 2017, and the incidence seems to be higher than reported in previous studies., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
21. Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States.
- Author
-
Mandelbaum RS, Matsuzaki S, Sangara RN, Klar M, Matsushima K, Roman LD, Paulson RJ, Wright JD, and Matsuo K
- Subjects
- Adolescent, Adult, Cesarean Section, Female, Humans, Middle Aged, Pregnancy, Retrospective Studies, Salpingectomy, United States, Young Adult, Ovarian Neoplasms epidemiology, Ovarian Neoplasms prevention & control, Ovarian Neoplasms surgery, Sterilization, Tubal
- Abstract
Background: Opportunistic salpingectomy is now recommended at the time of routine gynecologic surgery to reduce the risk of future ovarian cancer, and performance of opportunistic salpingectomy has increased markedly at the time of benign hysterectomy. Salpingectomy has also been suggested to be feasible at the time of cesarean delivery in women desiring sterilization; however, uptake has not been previously studied on a national level., Objective: This study aimed to examine recent population trends in the utilization and characteristics of salpingectomy at the time of cesarean delivery in the United States., Study Design: This is a population-based retrospective observational study querying the National Inpatient Sample between October 2015 and December 2018. The primary outcome measure was the temporal trend of bilateral salpingectomy at cesarean delivery, assessed with linear segmented regression with log transformation utilizing 3-month time increments. The secondary outcome measures included patient characteristics associated with bilateral salpingectomy, assessed with a multinomial regression model, and surgical outcome (hemorrhage, blood transfusion, hysterectomy, and oophorectomy) at the time of bilateral salpingectomy vs bilateral tubal ligation, assessed with generalized estimating equation in a propensity score-matched model., Results: There were 3,813,823 women at the age of 15 to 49 years who had cesarean deliveries included, of whom 397,260 (10.4%) had bilateral salpingectomy and 203,400 (5.3%) had bilateral tubal ligation overall. During the time period studied, performance of bilateral salpingectomy among women undergoing cesarean delivery significantly increased from 4.6% to 13.2% (odds ratio for the fourth quarter of 2018 vs the fourth quarter of 2015, 2.69; 95% confidence interval, 2.63-2.75; Figure panel). In contrast, performance of bilateral tubal ligation among women undergoing cesarean delivery significantly decreased from 11.3% to 2.4% (odds ratio, 0.20; 95% confidence interval, 0.19-0.21). By the third quarter of 2016, the number of women who had bilateral salpingectomy exceeded those who had bilateral tubal ligation at cesarean delivery (8.6% vs 7.3%). Increasing the utilization of bilateral salpingectomy did not vary across age groups; the salpingectomy rate increased from 7.5% to 21.1% among women at the age of ≥35 years and from 3.8% to 10.7% among women at the age of <35 years (both, P<.001). In a propensity score matched model, women in the bilateral salpingectomy group were more likely to have hemorrhage (3.8% vs 3.1%; odds ratio, 1.24; 95% confidence interval, 1.15-1.33), blood product transfusion (2.1% vs 1.8%; odds ratio, 1.16; 95% confidence interval, 1.04-1.30), hysterectomy (0.8% vs 0.4%; odds ratio, 2.28; 95% confidence interval, 1.84-2.82), and oophorectomy (0.3% vs 0.2%; odds ratio, 2.02; 95% confidence interval, 1.47-2.79) than those in the bilateral tubal ligation group. When restricted to the nonhysterectomy cases, the bilateral salpingectomy group had a higher rate of hemorrhage (3.4% vs 3.0%; odds ratio, 1.16; 95% confidence interval, 1.06-1.26) and oophorectomy (0.3% vs 0.1%; odds ratio, 1.75; 95% confidence interval, 1.22-2.50) than the bilateral tubal ligation group., Conclusion: In the United States, the utilization of bilateral salpingectomy at the time of cesarean delivery increased rapidly between 2015 and 2018, replacing tubal ligation as the most common type of sterilization performed with cesarean delivery. The higher surgical morbidity in the bilateral salpingectomy group than the bilateral tubal ligation group observed in this study warrants further investigation., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
22. Ovarian conservation for young women with early-stage, low-grade endometrial cancer: a 2-step schema.
- Author
-
Matsuo K, Mandelbaum RS, Matsuzaki S, Klar M, Roman LD, and Wright JD
- Subjects
- Adult, Age Factors, Aged, Aged, 80 and over, Carcinoma, Endometrioid diagnosis, Carcinoma, Endometrioid pathology, Clinical Decision-Making methods, Endometrial Neoplasms diagnosis, Endometrial Neoplasms pathology, Female, Humans, Menopause, Middle Aged, Neoplasm Grading, Neoplasm Metastasis, Neoplasm Recurrence, Local diagnosis, Neoplasm Recurrence, Local etiology, Neoplasm Recurrence, Local prevention & control, Neoplasm Staging, Ovarian Neoplasms diagnosis, Ovarian Neoplasms secondary, Ovarian Neoplasms surgery, Ovariectomy adverse effects, Risk Assessment, Carcinoma, Endometrioid surgery, Endometrial Neoplasms surgery, Fertility Preservation methods, Hysterectomy methods, Organ Sparing Treatments methods, Perioperative Care methods
- Abstract
In 2020, endometrial cancer continues to be the most common gynecologic malignancy in the United States. The majority of endometrial cancer is low grade, and nearly 1 of every 8 low-grade endometrial cancer diagnoses occurs in women younger than 50 years with early-stage disease. The incidence of early-stage, low-grade endometrial cancer is increasing particularly among women in their 30s. Women with early-stage, low-grade endometrial cancer generally have a favorable prognosis, and hysterectomy-based surgical treatment alone can often be curative. In young women with endometrial cancer, consideration of ovarian conservation is especially relevant to avoid both the short-term and long-term sequelae of surgical menopause including menopausal symptoms, cardiovascular disease, metabolic disease, and osteoporosis. Although disadvantages of ovarian conservation include failure to remove ovarian micrometastasis (0.4%-0.8%), gross ovarian metastatic disease (4.2%), or synchronous ovarian cancer (3%-5%) at the time of surgery and the risk of future potential metachronous ovarian cancer (1.2%), ovarian conservation is not negatively associated with endometrial cancer-related or all-cause mortality in young women with early-stage, low-grade endometrial cancer. Despite this, utilization of ovarian conservation for young women with early-stage, low-grade endometrial cancer remains modest with only a gradual increase in uptake in the United States. We propose a framework and strategic approach to identify young women with early-stage, low-grade endometrial cancer who may be candidates for ovarian conservation. This evidence-based schema consists of a 2-step assessment at both the preoperative and intraoperative stages that can be universally integrated into practice., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
23. Proposal of an endometrial cancer staging schema with stage-specific incorporation of malignant peritoneal cytology.
- Author
-
Matsuo K, Matsuzaki S, Roman LD, Klar M, and Wright JD
- Subjects
- Female, Humans, Retrospective Studies, Endometrial Neoplasms pathology, Neoplasm Staging methods, Peritoneum pathology
- Published
- 2021
- Full Text
- View/download PDF
24. CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma.
- Author
-
Nakae R, Matsuzaki S, Serada S, Matsuo K, Shiomi M, Sato K, Nagase Y, Matsuzaki S, Nakagawa S, Hiramatsu K, Okazawa A, Kimura T, Egawa-Takata T, Kobayashi E, Ueda Y, Yoshino K, Naka T, and Kimura T
- Subjects
- Animals, Antibodies, Monoclonal immunology, Antibodies, Monoclonal therapeutic use, Blotting, Western, Cell Line, Tumor, Cell Survival drug effects, Female, Flow Cytometry, Humans, Leiomyosarcoma drug therapy, Mice, Middle Aged, Neoplasm Transplantation, Oligopeptides therapeutic use, Proteomics, Uterine Neoplasms drug therapy, Xenograft Model Antitumor Assays, Antibodies, Monoclonal pharmacology, CD27 Ligand immunology, Cell Proliferation drug effects, Immunoconjugates therapeutic use, Leiomyosarcoma metabolism, Myometrium metabolism, Oligopeptides pharmacology, Uterine Neoplasms metabolism
- Abstract
Background: Uterine leiomyosarcoma is a rare and aggressive gynecologic malignancy originating in the myometrium of the uterine corpus that tends to recur even after complete surgical excision. Current therapeutic agents have only modest effects on uterine leiomyosarcoma. Although antibodies and antibody-drug conjugates have been recognized as useful targeted therapies for other cancers, no study has yet evaluated the effects of this approach on uterine leiomyosarcoma., Objective: This study aimed to examine the activity of tumoral CD70 in uterine leiomyosarcoma and assess the antitumor activity of CD70-antibody-drug conjugate treatment in uterine leiomyosarcoma., Study Design: Target membrane proteins were screened by profiling and comparing membrane protein expression in 3 uterine leiomyosarcoma cell lines (SK-UT-1, SK-LMS-1, and SKN) and normal uterine myometrium cells using the isobaric tags for relative and absolute quantitation labeling method. Western blotting, fluorescence-activated cell sorting analyses, and immunohistochemistry were used to examine CD70 expression in the membrane proteins in uterine leiomyosarcoma cell lines and clinical samples. We developed an antibody-drug conjugate with a monoclonal antibody of the target membrane protein linked to monomethyl auristatin F and investigated its antitumor effects against uterine leiomyosarcoma (in vitro, in vivo, and in patient-derived xenograft models)., Results: CD70 was identified as a specific antigen highly expressed in uterine leiomyosarcoma cell lines. Of the 3 uterine leiomyosarcoma cell lines, CD70 expression was confirmed in SK-LMS-1 cells by western blotting and fluorescence-activated cell sorting analysis. CD70 overexpression was observed in 19 of 21 (90.5%) tumor specimens from women with uterine leiomyosarcoma. To generate CD70-antibody-drug conjugate, anti-CD70 monoclonal antibody was conjugated with a novel derivative of monomethyl auristatin F. CD70-antibody-drug conjugate showed significant antitumor effects on SK-LMS-1 cells (half maximal inhibitory concentration, 0.120 nM) and no antitumor effects on CD70-negative uterine leiomyosarcoma cells. CD70-antibody-drug conjugate significantly inhibited tumor growth in the SK-LMS-1 xenograft mouse model (tumor volume, 129.8 vs 285.5 mm
3 ; relative reduction, 54.5%; P<.001) and patient-derived xenograft mouse model (tumor volume, 128.1 vs 837.7 mm3 ; relative reduction, 84.7%; P<.001)., Conclusion: Uterine leiomyosarcoma tumors highly express CD70 and targeted therapy with CD70-antibody-drug conjugate may have a potential therapeutic implication in the treatment of uterine leiomyosarcoma., (Copyright © 2020 Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
25. Reply.
- Author
-
Mandelbaum RS, Matsuzaki S, Wright JD, and Matsuo K
- Subjects
- Female, Humans, Hysterectomy, Time, United States, Genital Diseases, Female, Salpingectomy
- Published
- 2020
- Full Text
- View/download PDF
26. The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.
- Author
-
Mandelbaum RS, Adams CL, Yoshihara K, Nusbaum DJ, Matsuzaki S, Matsushima K, Klar M, Paulson RJ, Roman LD, Wright JD, and Matsuo K
- Subjects
- Adult, Aged, Female, Hospitals, Teaching trends, Hospitals, Urban trends, Humans, Interrupted Time Series Analysis, Middle Aged, Multivariate Analysis, Retrospective Studies, United States, Carcinoma, Ovarian Epithelial prevention & control, Hysterectomy, Ovarian Neoplasms prevention & control, Practice Patterns, Physicians' trends, Prophylactic Surgical Procedures trends, Salpingectomy trends, Uterine Diseases surgery
- Abstract
Background: Mounting evidence for the role of distal fallopian tubes in the pathogenesis of epithelial ovarian cancer has led to opportunistic salpingectomy being increasingly performed at the time of benign gynecologic surgery. Opportunistic salpingectomy has now been recommended as best practice in the United States to reduce future risk of ovarian cancer even in low-risk women. Preliminary analyses have suggested that performance of opportunistic salpingectomy is increasing., Objective: To examine trends in opportunistic salpingectomy in women undergoing benign hysterectomy and to determine how the publication of the tubal hypothesis in 2010 may have contributed to these trends., Study Design: This is a population-based, retrospective, observational study examining the National Inpatient Sample between January 2001 and September 2015. Women younger than 50 years who underwent inpatient hysterectomy for benign gynecologic disease were grouped as hysterectomy alone vs hysterectomy with opportunistic salpingectomy. All women had ovarian conservation, and those with adnexal pathology were excluded. Linear segmented regression with log transformation was used to assess temporal trends. An interrupted time-series analysis was then used to assess the impact of the 2010 publication of the tubal hypothesis on opportunistic salpingectomy trends. A regression-tree model was constructed to examine patterns in the use of opportunistic salpingectomy. A binary logistic regression model was then fitted to identify independent characteristics associated with opportunistic salpingectomy. Sensitivity analysis was performed in women aged 50-65 years to further assess surgical trends in a wider age group., Results: There were 98,061 (9.0%) women who underwent hysterectomy with opportunistic salpingectomy and 997,237 (91.0%) women who underwent hysterectomy alone without opportunistic salpingectomy. The rate at which opportunistic salpingectomy was being performed gradually increased from 2.4% to 5.7% between 2001 and 2010 (2.4-fold increase; P<.001), predicting a 7.0% rate of opportunistic salpingectomy in 2015. However, in 2010, the rate of opportunistic salpingectomy began to increase substantially and reached 58.4% by 2015 (10.2-fold increase; P<.001). In multivariable analysis, the largest change in the performance of opportunistic salpingectomy occurred after 2010 (adjusted odds ratio, 5.42; 95% confidence interval, 5.34-5.51; P<.001). In a regression-tree model, women who had a hysterectomy at urban teaching hospitals in the Midwest after 2013 had the highest chance of undergoing opportunistic salpingectomy during benign hysterectomy (76.4%). In the sensitivity analysis of women aged 50-65 years, a similar exponential increase in opportunistic salpingectomy was observed from 5.8% in 2010 to 55.8% in 2015 (9.8-fold increase; P<.001)., Conclusion: Our study suggests that clinicians in the United States rapidly adopted opportunistic salpingectomy at the time of benign hysterectomy following the publication of data implicating the distal fallopian tubes in ovarian cancer pathogenesis in 2010. By 2015, nearly 60% of women had undergone opportunistic salpingectomy at benign hysterectomy., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
27. A cesarean delivery sequela:: scar rupture and tumor spill during laparoscopic hysterectomy for endometrial cancer.
- Author
-
Miller H and Matsuo K
- Subjects
- Conversion to Open Surgery, Female, Humans, Hysterectomy, Laparoscopy, Middle Aged, Robotic Surgical Procedures, Salpingo-oophorectomy, Sentinel Lymph Node Biopsy, Carcinoma, Endometrioid surgery, Cesarean Section adverse effects, Cicatrix etiology, Endometrial Neoplasms surgery, Intraoperative Complications, Uterine Rupture
- Published
- 2020
- Full Text
- View/download PDF
28. Delayed hysterectomy versus continuing conservative management for placenta percreta: which is better?
- Author
-
Matsuzaki S, Grubbs BH, and Matsuo K
- Subjects
- Algorithms, Conservative Treatment, Female, Humans, Hysterectomy, Pregnancy, Placenta Accreta surgery, Postpartum Hemorrhage
- Published
- 2020
- Full Text
- View/download PDF
29. Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapy.
- Author
-
Mandelbaum RS, Ciccone MA, Nusbaum DJ, Khoshchehreh M, Purswani H, Morocco EB, Smith MB, Matsuzaki S, Dancz CE, Ozel B, Roman LD, Paulson RJ, and Matsuo K
- Subjects
- Adult, Female, Humans, Progestins therapeutic use, Retrospective Studies, Treatment Outcome, Endometrial Hyperplasia complications, Endometrial Hyperplasia drug therapy, Intrauterine Devices, Medicated, Levonorgestrel administration & dosage, Obesity, Morbid congenital, Progestins administration & dosage
- Abstract
Background: Though hysterectomy remains the standard treatment for complex atypical hyperplasia, patients who desire fertility or who are poor surgical candidates may opt for progestin therapy. However, the effectiveness of the levonorgestrel-releasing intrauterine device compared to systemic therapy in the treatment of complex atypical hyperplasia has not been well studied., Objective: We sought to examine differences in treatment response between local progestin therapy with the levonorgestrel-releasing intrauterine device and systemic progestin therapy in women with complex atypical hyperplasia., Methods: This single-institution retrospective study examined women with complex atypical hyperplasia who received progestin therapy between 2003 and 2018. Treatment response was assessed by histopathology on subsequent biopsies. Time-dependent analyses of complete response and progression to cancer were performed comparing the levonorgestrel-releasing intrauterine device and systemic therapy. A propensity score inverse probability of treatment weighting model was used to create a weighted cohort that differed based on treatment type but was similar with respect to other characteristics. An interaction-term analysis was performed to examine the impact of body habitus on treatment response, and an interrupted time-series analysis was employed to assess if changes in treatment patterns correlated with outcomes over time., Results: A total of 245 women with complex atypical hyperplasia received progestin therapy (levonorgestrel-releasing intrauterine device n = 69 and systemic therapy n = 176). The mean age and body mass index were 36.9 years and 40.0 kg/m
2 , respectively. In the patient-level analysis, women who received the levonorgestrel-releasing intrauterine device had higher rates of complete response (78.7% vs 46.7%; adjusted hazard ratio, 3.32; 95% confidence interval, 2.39-4.62) and a lower likelihood of progression to cancer (4.5% vs 15.7%; adjusted hazard ratio, 0.28; 95% confidence interval, 0.11-0.73) compared to those who received systemic therapy. In particular, women with class III obesity derived a higher relative benefit from levonorgestrel-releasing intrauterine device therapy in achieving complete response compared to systemic therapy: class III obesity, adjusted hazard ratio 4.72, 95% confidence interval 2.83-7.89; class I-II obesity, adjusted hazard ratio 1.83, 95% confidence interval 1.09-3.09; and nonobese, adjusted hazard ratio 1.26, 95% confidence interval 0.40-3.95. In the cohort-level analysis, the obesity rate increased during the study period (77.8% to 88.2%, 13.4% relative increase, P = .033) and levonorgestrel-releasing intrauterine device use significantly increased after 2007 (6.3% to 82.7%, 13.2-fold increase, P < .001), both concomitant with a higher proportion of women achieving complete response (32.9% to 81.4%, 2.5-fold increase, P = .005)., Conclusion: Our study suggests that local therapy with the levonorgestrel-releasing intrauterine device may be more effective than systemic therapy for women with complex atypical hyperplasia who opt for nonsurgical treatment, particularly in morbidly obese women. Shifts in treatment paradigm during the study period toward increased levonorgestrel-releasing intrauterine device use also led to improved complete response rates despite increasing rates of obesity., (Copyright © 2020 Elsevier Inc. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
30. Cesarean radical hysterectomy for cervical cancer in the United States: a national study of surgical outcomes.
- Author
-
Matsuo K, Mandelbaum RS, Matsuzaki S, Licon E, Roman LD, Klar M, and Grubbs BH
- Subjects
- Adult, Black or African American, Age Distribution, Carcinoma pathology, Case-Control Studies, Cesarean Section statistics & numerical data, Databases, Factual, Female, Hispanic or Latino, Hospital Bed Capacity, Hospital Charges, Hospitals, Teaching, Hospitals, Urban, Humans, Hysterectomy statistics & numerical data, Income, Length of Stay, Medicaid, Middle Aged, Neoplasm Staging, Pregnancy, Pregnancy Complications, Neoplastic pathology, Retrospective Studies, United States epidemiology, Uterine Cervical Neoplasms pathology, White People, Carcinoma surgery, Cesarean Section methods, Hysterectomy methods, Lymph Node Excision statistics & numerical data, Postoperative Complications epidemiology, Pregnancy Complications, Neoplastic surgery, Uterine Cervical Neoplasms surgery
- Published
- 2020
- Full Text
- View/download PDF
31. Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone.
- Author
-
Matsuo K, Nusbaum DJ, Machida H, Huang Y, Khetan V, Matsuzaki S, Klar M, Grubbs BH, Roman LD, and Wright JD
- Subjects
- Adenocarcinoma pathology, Adult, Aged, Carcinoma, Adenosquamous pathology, Carcinoma, Adenosquamous therapy, Carcinoma, Squamous Cell pathology, Cohort Studies, Female, Humans, Lymph Node Excision, Lymphatic Metastasis, Middle Aged, Neoplasm Staging, Pelvis, Propensity Score, Proportional Hazards Models, SEER Program, Survival Rate, Uterine Cervical Neoplasms pathology, Adenocarcinoma therapy, Carcinoma, Squamous Cell therapy, Chemoradiotherapy, Adjuvant trends, Hysterectomy, Lymph Nodes pathology, Radiotherapy, Adjuvant trends, Uterine Cervical Neoplasms therapy
- Abstract
Background: Pelvic lymph node metastasis carries the highest impact on decreased survival among surgical-pathological risk factors for early-stage cervical cancer. Although concurrent administration of chemotherapy during postoperative radiotherapy is the current standard treatment for surgically treated high-risk early-stage cervical cancer, its effectiveness specific to node-positive disease has not been completely studied., Objective: To examine the association between the use of concurrent chemotherapy and survival in women with early-stage cervical cancer and nodal metastasis receiving adjuvant radiotherapy., Materials and Methods: This is a population-based cohort study using the Surveillance, Epidemiology, and End Results Program from 1988 to 2016. Women with stage T1-2 cervical cancer with pelvic lymph node metastasis who underwent hysterectomy and received postoperative radiotherapy were examined. Trends, characteristics, and overall survival were compared between women who received postoperative radiotherapy alone (n = 729) or in combination with concurrent chemo-radiotherapy (n = 1809). Propensity score-based inverse probability of treatment weighting was used to account for the effect of measured covariates on treatment selection., Results: Among 2538 women, there was a marked increase in the use of concurrent chemotherapy from 1997 to 2000 (20.7% to 78.5%, P = .052), followed by a more gradual rise through 2016 (88.3%, P < .001). In a multivariable model, women with non-squamous cell carcinomas and those diagnosed more recently were more likely to receive concurrent chemo-radiotherapy, whereas older women were less likely to receive concurrent chemo-radiotherapy (all, P < .05). At the population level, the 5-year overall survival rates remained unchanged (annual percent change for 1997-2012: -0.1; 95% confidence interval, -1.2 to 1.0; P = .776). In a propensity score weighted cohort, women who received concurrent chemo-radiotherapy had a 5-year overall survival rate similar to women treated with radiotherapy alone (73.1% vs 73.6%; hazard ratio, 1.004; 95% confidence interval, 0.887-1.136; P = .955). Significant differences were also not seen in older women, nonsquamous types, stage T2 disease, and multiple node metastases (all, P > .05)., Conclusion: Despite the marked increase in the use of concurrent chemo-radiotherapy for women with early-stage cervical cancer and nodal metastases, there was no association between use of concurrent chemotherapy during postoperative radiotherapy and improved survival., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
32. Reply.
- Author
-
Matsuo K, Melamed A, and Wright JD
- Subjects
- Adult, Female, Humans, Laparotomy, Minimally Invasive Surgical Procedures, Reproduction, Trachelectomy, Uterine Cervical Neoplasms
- Published
- 2019
- Full Text
- View/download PDF
33. Trachelectomy for reproductive-aged women with early-stage cervical cancer: minimally invasive surgery versus laparotomy.
- Author
-
Matsuo K, Chen L, Mandelbaum RS, Melamed A, Roman LD, and Wright JD
- Subjects
- Adenocarcinoma mortality, Adenocarcinoma pathology, Adenocarcinoma surgery, Adult, Carcinoma, Squamous Cell mortality, Carcinoma, Squamous Cell pathology, Carcinoma, Squamous Cell surgery, Female, Fertility Preservation, Follow-Up Studies, Humans, Laparoscopy trends, Registries, Retrospective Studies, Robotic Surgical Procedures trends, Trachelectomy trends, United States epidemiology, Uterine Cervical Neoplasms mortality, Uterine Cervical Neoplasms pathology, Laparoscopy statistics & numerical data, Laparotomy statistics & numerical data, Robotic Surgical Procedures statistics & numerical data, Trachelectomy statistics & numerical data, Uterine Cervical Neoplasms surgery
- Abstract
Background: A recent trial demonstrated decreased survival in women with early-stage cervical cancer who underwent radical hysterectomy via minimally invasive surgery compared with laparotomy; however, outcomes following trachelectomy have yet to be studied., Objective: To examine trends, characteristics, and survival of reproductive-aged women with early-stage cervical cancer who underwent minimally invasive trachelectomy., Study Design: This is a retrospective study examining the National Cancer Database between 2010 and 2015. Women aged <50 years who underwent trachelectomy for stage IA2-IB cervical cancer were grouped by mode of surgery. Clinicopathologic characteristics and outcomes were compared between minimally invasive surgery and laparotomy groups., Results: A total of 246 women were included, 144 (58.5%, 95% confidence interval, 52.4%-64.7%) of whom had trachelectomy with a minimally invasive surgery approach. Median age was similar between the minimally invasive surgery and laparotomy groups (median, 31 vs 29 years, P = .20). There was a significant increase in the use of minimally invasive surgery from 29.3% in 2010 to 75.0% in 2015 (P < .001). Specifically, minimally invasive surgery became the dominant approach for trachelectomy by year 2011 (54.8%). Hospitals registered in the West (75.0% vs 25.0%) were more likely, whereas those registered in the Midwest (46.9% vs 53.1%) were less likely, to perform minimally invasive surgery (P = .02). Median follow-up was 37 months (interquartile range, 23-51) for the minimally invasive surgery group and 40 months (interquartile range, 26-67) for the laparotomy group. During follow-up, there were 11 (5.3%) deaths, 4 (3.5%) in the minimally invasive surgery group and 7 (7.6%) in the laparotomy group (P = .25)., Conclusion: Minimally invasive surgery has become the dominant modality for trachelectomy in reproductive-aged women with stage IA2-IB cervical cancer after year 2011. Survival of women with stage IA2-IB cervical cancer who underwent trachelectomy is generally good regardless of surgical modality. Although our study showed no difference in survival between the minimally invasive surgery and laparotomy approaches, effects of MIS on survival remain unknown and further study is warranted., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
34. Survival outcome prediction in cervical cancer: Cox models vs deep-learning model.
- Author
-
Matsuo K, Purushotham S, Jiang B, Mandelbaum RS, Takiuchi T, Liu Y, and Roman LD
- Subjects
- Adenocarcinoma pathology, Adenocarcinoma therapy, Adult, Carcinoma, Squamous Cell pathology, Carcinoma, Squamous Cell therapy, Comorbidity, Female, Humans, Middle Aged, Neoplasm Staging, Pilot Projects, Progression-Free Survival, Retrospective Studies, Risk Assessment, Survival Analysis, Uterine Cervical Neoplasms pathology, Uterine Cervical Neoplasms therapy, Adenocarcinoma mortality, Carcinoma, Squamous Cell mortality, Deep Learning, Proportional Hazards Models, Uterine Cervical Neoplasms mortality
- Abstract
Background: Historically, the Cox proportional hazard regression model has been the mainstay for survival analyses in oncologic research. The Cox proportional hazard regression model generally is used based on an assumption of linear association. However, it is likely that, in reality, there are many clinicopathologic features that exhibit a nonlinear association in biomedicine., Objective: The purpose of this study was to compare the deep-learning neural network model and the Cox proportional hazard regression model in the prediction of survival in women with cervical cancer., Study Design: This was a retrospective pilot study of consecutive cases of newly diagnosed stage I-IV cervical cancer from 2000-2014. A total of 40 features that included patient demographics, vital signs, laboratory test results, tumor characteristics, and treatment types were assessed for analysis and grouped into 3 feature sets. The deep-learning neural network model was compared with the Cox proportional hazard regression model and 3 other survival analysis models for progression-free survival and overall survival. Mean absolute error and concordance index were used to assess the performance of these 5 models., Results: There were 768 women included in the analysis. The median age was 49 years, and the majority were Hispanic (71.7%). The majority of tumors were squamous (75.3%) and stage I (48.7%). The median follow-up time was 40.2 months; there were 241 events for recurrence and progression and 170 deaths during the follow-up period. The deep-learning model showed promising results in the prediction of progression-free survival when compared with the Cox proportional hazard regression model (mean absolute error, 29.3 vs 316.2). The deep-learning model also outperformed all the other models, including the Cox proportional hazard regression model, for overall survival (mean absolute error, Cox proportional hazard regression vs deep-learning, 43.6 vs 30.7). The performance of the deep-learning model further improved when more features were included (concordance index for progression-free survival: 0.695 for 20 features, 0.787 for 36 features, and 0.795 for 40 features). There were 10 features for progression-free survival and 3 features for overall survival that demonstrated significance only in the deep-learning model, but not in the Cox proportional hazard regression model. There were no features for progression-free survival and 3 features for overall survival that demonstrated significance only in the Cox proportional hazard regression model, but not in the deep-learning model., Conclusion: Our study suggests that the deep-learning neural network model may be a useful analytic tool for survival prediction in women with cervical cancer because it exhibited superior performance compared with the Cox proportional hazard regression model. This novel analytic approach may provide clinicians with meaningful survival information that potentially could be integrated into treatment decision-making and planning. Further validation studies are necessary to support this pilot study., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
35. Characteristics and outcomes of reproductive-aged women with early-stage cervical cancer: trachelectomy vs hysterectomy.
- Author
-
Machida H, Mandelbaum RS, Mikami M, Enomoto T, Sonoda Y, Grubbs BH, Paulson RJ, Roman LD, Wright JD, and Matsuo K
- Subjects
- Adult, Female, Humans, Neoplasm Staging, Propensity Score, Proportional Hazards Models, Retrospective Studies, SEER Program, Survival Rate, Treatment Outcome, Uterine Cervical Neoplasms pathology, Hysterectomy statistics & numerical data, Trachelectomy statistics & numerical data, Uterine Cervical Neoplasms mortality, Uterine Cervical Neoplasms surgery
- Abstract
Background: Trachelectomy is the treatment of choice for reproductive-aged women with early-stage cervical cancer who desire future fertility. Comprehensive population-based statistics have been missing to date., Objective: We sought to compare characteristics and survival of reproductive-aged women who underwent trachelectomy for early-stage cervical cancer to those who had hysterectomy., Study Design: This is a retrospective observational study examining the Surveillance, Epidemiology, and End Results program from 1998 through 2014. Women <45 years of age with stage IA and IB1 (tumor size ≤2 cm) cervical cancer who underwent trachelectomy were compared to those who underwent hysterectomy. Multivariable models were used to identify clinicopathological factors associated with trachelectomy. Survival was compared between the 2 groups after propensity score matching., Results: Among 6359 women, 190 (3.0%; 95% confidence interval, 2.6-3.4) underwent trachelectomy. The median age of the trachelectomy group was 31 years (interquartile range, 28-34). The proportion of women who underwent trachelectomy significantly increased during the study period (1.2% in 1998 through 2002, 3.0% in 2003 through 2008, and 4.5% in 2009 through 2014, P < .001). Younger age, nonblack race, single marital status, eastern registry area, recent disease diagnosis, nonsquamous histology, and higher stage were independent factors associated with trachelectomy use (all, adjusted P < .05). After propensity score matching, 5-year cause-specific survival (96.9% vs 96.6%; hazard ratio, 0.73; 95% confidence interval, 0.23-2.30; P = .59) and overall survival (96.1% vs 96.6%; hazard ratio, 0.76; 95% confidence interval, 0.26-2.20; P = .61) were similar between the trachelectomy group and the hysterectomy group., Conclusion: Our study found that there was a significant increase in the proportion of reproductive-aged women with stage IA or IB1 (≤2 cm) cervical cancer who underwent trachelectomy in recent years. Survival with trachelectomy was similar to those who had hysterectomy in this population., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
36. Reply.
- Author
-
Matsuo K, Roman LD, and Wright JD
- Published
- 2018
- Full Text
- View/download PDF
37. A pilot study in using deep learning to predict limited life expectancy in women with recurrent cervical cancer.
- Author
-
Matsuo K, Purushotham S, Moeini A, Li G, Machida H, Liu Y, and Roman LD
- Subjects
- Clinical Decision-Making, Female, Humans, Linear Models, Pilot Projects, Prognosis, Retrospective Studies, Decision Support Techniques, Life Expectancy, Machine Learning, Neoplasm Recurrence, Local mortality, Neural Networks, Computer, Uterine Cervical Neoplasms mortality
- Published
- 2017
- Full Text
- View/download PDF
38. Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer.
- Author
-
Matsuo K, Machida H, Horowitz MP, Shahzad MMK, Guntupalli SR, Roman LD, and Wright JD
- Subjects
- Adenocarcinoma pathology, Adult, Carcinoma, Adenosquamous pathology, Carcinoma, Squamous Cell pathology, Female, Humans, Middle Aged, Neoplasm Staging, Organ Sparing Treatments, Ovary, Proportional Hazards Models, Radiotherapy, Adjuvant, SEER Program, Time Factors, Uterine Cervical Neoplasms pathology, Adenocarcinoma surgery, Carcinoma, Adenosquamous surgery, Carcinoma, Squamous Cell surgery, Hysterectomy methods, Neoplasms, Second Primary epidemiology, Ovarian Neoplasms epidemiology, Uterine Cervical Neoplasms surgery
- Abstract
Background: While there is an increasing trend of ovarian conservation at the time of surgical treatment for young women with stage I cervical cancer, the risk for subsequent ovarian cancer after ovarian conservation has not been well studied., Objective: We sought to examine the incidence of and risk factors for metachronous ovarian cancer among young women with stage I cervical cancer who had ovarian conservation at the time of hysterectomy., Study Design: The Surveillance, Epidemiology, and End Results Program was used to identify women aged <50 years who underwent hysterectomy with ovarian conservation for stage I cervical cancer from 1983 through 2013 (n = 4365). Time-dependent analysis was performed for ovarian cancer risk after cervical cancer diagnosis., Results: Mean age at cervical cancer diagnosis was 37 years, and the majority of patients had stage IA disease (68.2%) and squamous histology (72.9%). Median follow-up time was 10.8 years, and there were 13 women who developed metachronous ovarian cancer. The 10- and 20-year cumulative incidences of metachronous ovarian cancer were 0.2% (95% confidence interval, 0.1-0.4) and 0.5% (95% confidence interval, 0.2-0.8), respectively. Mean age at the time of diagnosis of metachronous ovarian cancer was 47.5 years, and stage III-IV disease was seen in 55.6%. Age (≥45 vs <45 years, hazard ratio, 4.22; 95% confidence interval, 1.16-15.4; P = .018), ethnicity (non-white vs white, hazard ratio, 4.29; 95% confidence interval, 1.31-14.0; P = .009), cervical cancer histology (adenocarcinoma or adenosquamous vs squamous, hazard ratio, 3.50; 95% confidence interval, 1.17-10.5; P = .028), and adjuvant radiotherapy use (yes vs no, hazard ratio, 3.69; 95% confidence interval, 1.01-13.4; P = .034) were significantly associated with metachronous ovarian cancer risk. The presence of multiple risk factors was associated with a significantly increased risk of metachronous ovarian cancer compared to the no risk factor group: 1 risk factor (hazard ratio range, 2.96-8.43), 2 risk factors (hazard ratio range, 16.6-31.0), and 3-4 risk factors (hazard ratio range, 62.3-109), respectively., Conclusion: Metachronous ovarian cancer risk after ovarian conservation for women with stage I cervical cancer is <1%. Older age, non-white ethnicity, adenocarcinoma or adenosquamous histology, and adjuvant radiotherapy may be associated with an increased metachronous ovarian cancer risk., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
39. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
- Author
-
Tierney KE, Lin PS, Amezcua C, Matsuo K, Ye W, Felix JC, and Roman LD
- Subjects
- Adenocarcinoma pathology, Adult, Carcinoma in Situ pathology, Curettage, Female, Humans, Hysterectomy, Middle Aged, Neoplasm Invasiveness, Neoplasm, Residual, Neoplasms, Multiple Primary pathology, Reoperation, Uterine Cervical Neoplasms pathology, Young Adult, Adenocarcinoma surgery, Carcinoma in Situ surgery, Conization, Neoplasms, Multiple Primary surgery, Uterine Cervical Neoplasms surgery
- Abstract
Objective: To determine factors associated with the presence of residual disease in women who have undergone cervical conization for adenocarcinoma in situ (ACIS) of the cervix., Study Design: We identified women who underwent a cervical conization for a diagnosis of ACIS followed by repeat conization or hysterectomy between Jan. 1, 1995, and April 30, 2010. Data were summarized using standard descriptive statistics., Results: Seventy-eight patients met study criteria. The presence of ACIS at the internal conization margin or in the postconization endocervical curettage (ECC) correlated with residual ACIS (P < .001). A margin positive for ACIS was associated with residual glandular neoplasia in 68% of cases. An endocervical curettage positive for ACIS was associated with residual ACIS in 95% of cases. If both the margins and the endocervical curettage were positive for the presence of ACIS, 8% did not have residual disease, 77% had residual ACIS, and 15% had invasive adenocarcinoma. If both the internal conization margin and the postconization ECC were negative for the presence of ACIS, 14% of the final specimens had residual ACIS and none had invasive cancer., Conclusion: The addition of postconization ECC to cone biopsy for ACIS of the cervix provides valuable prognostic information regarding the risk of residual ACIS. Women with ACIS who have both a negative postconization ECC and a negative conization margin have a 14% risk for residual ACIS and can be treated conservatively if desiring fertility. A positive postconization ECC or internal margin incurs significant risk of residual disease and 12-17% will have cancer., (Copyright © 2014 Mosby, Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
40. Outcomes of hysterectomies performed by supervised residents vs those performed by attendings alone.
- Author
-
Akingba DH, Deniseiko-Sanses TV, Melick CF, Ellerkmann RM, and Matsuo K
- Subjects
- Adult, Cohort Studies, Education, Medical, Graduate, Female, Follow-Up Studies, Gynecologic Surgical Procedures education, Health Care Surveys, Hospitals, Teaching, Humans, Hysterectomy adverse effects, Length of Stay trends, Middle Aged, Organization and Administration, Outcome Assessment, Health Care, Postoperative Complications epidemiology, Probability, Retrospective Studies, Risk Assessment, Treatment Outcome, Clinical Competence, Hysterectomy methods, Internship and Residency methods, Medical Staff, Hospital
- Abstract
Objective: The objective of the study was to compare the outcomes of hysterectomies performed by residents under supervision of a teaching physician with those performed by attendings alone., Study Design: This was a retrospective cohort analysis of hysterectomies performed at the Greater Baltimore Medical Center from 2004 to 2006., Results: Of 159 nonteaching and 265 teaching cases, there was no significant difference in any of the surgical outcomes, except mean operating room time in minutes (94.8 [+/- 47.0] vs 107.4 [+/- 42.4]; P = .005), seromas (2.5% vs 0%; P = .02), and others (5% vs 0.8%; P = .007) in nonteaching vs teaching cases, respectively. The demographics and comorbidities were similar. The mean operating room time difference of 13 minutes was not clinically significant., Conclusion: Although teaching hysterectomies take a bit longer to perform, there were no greater adverse outcomes.
- Published
- 2008
- Full Text
- View/download PDF
41. A rapid-growing uterine mass during pregnancy: a fast-growing uterine mass complicated a first pregnancy.
- Author
-
Matsuo K, Mighty HE, Im DD, and Rosenshein NB
- Subjects
- Adult, Female, Humans, Leiomyoma diagnostic imaging, Magnetic Resonance Imaging, Pregnancy, Pregnancy Complications, Neoplastic diagnostic imaging, Ultrasonography, Prenatal, Uterine Neoplasms diagnostic imaging, Leiomyoma pathology, Pregnancy Complications, Neoplastic pathology, Uterine Neoplasms pathology
- Published
- 2008
- Full Text
- View/download PDF
42. Anaphylactoid syndrome of pregnancy immediately after intrauterine pressure catheter placement.
- Author
-
Matsuo K, Lynch MA, Kopelman JN, and Atlas RO
- Subjects
- Adult, Anaphylaxis etiology, Cardiopulmonary Resuscitation, Delivery, Obstetric, Diagnosis, Differential, Disseminated Intravascular Coagulation etiology, Female, Humans, Infant, Newborn, Obstetric Labor Complications etiology, Pregnancy, Pressure, Anaphylaxis diagnosis, Catheterization adverse effects, Disseminated Intravascular Coagulation diagnosis, Obstetric Labor Complications diagnosis, Prenatal Diagnosis
- Abstract
A 35-year-old multipara woman underwent intrauterine pressure catheter placement during labor. Immediately afterwards, she had severe dyspnea develop, became unresponsive, and had a prolonged fetal bradycardia. During emergency cesarean section, she required cardiopulmonary resuscitation repetitively. She then had disseminated intravascular coagulopathy develop and underwent hysterectomy. Anaphylactic reaction may be associated with intrauterine pressure catheter placement.
- Published
- 2008
- Full Text
- View/download PDF
43. The big seep.
- Author
-
Matsuo K, Rosenshein NB, and Im DD
- Subjects
- Cystoscopy, Female, Follow-Up Studies, Humans, Hysterectomy methods, Leiomyoma diagnosis, Leiomyoma surgery, Middle Aged, Nephrostomy, Percutaneous methods, Risk Assessment, Treatment Outcome, Ureter surgery, Urinary Catheterization, Urination Disorders diagnosis, Urination Disorders etiology, Urination Disorders surgery, Urography, Uterine Neoplasms diagnosis, Uterine Neoplasms surgery, Vesicovaginal Fistula diagnosis, Hysterectomy adverse effects, Ureter injuries, Vesicovaginal Fistula etiology, Vesicovaginal Fistula surgery
- Published
- 2008
- Full Text
- View/download PDF
44. Uterine varices during pregnancy.
- Author
-
Matsuo K and Kimura T
- Subjects
- Adult, Cesarean Section, Repeat adverse effects, Female, Humans, Parity, Pregnancy, Uterus pathology, Placenta Previa surgery, Pregnancy Complications, Cardiovascular, Uterus blood supply, Varicose Veins
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.